Peptide United

Research comparison

Ipamorelin vs GHRP-2

Side-by-side comparison of research status, mechanisms, pharmacokinetics, and administration routes.

Ipamorelin

NNC 26-0161

Preclinical

Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist. Unlike other GHRPs, it stimulates GH release with high selectivity — producing minimal cortisol, ACTH, or prolactin elevation. It is among the most studied GHRPs for its clean GH pulse profile, making it a preferred research peptide for GH axis studies with reduced side effect concern.

Research Status

Preclinical Research

Half-Life

~2 hours

Molecular Formula

C₃₈H₄₉N₉O₅

Molecular Weight

711.86 Da

CAS Number

170851-70-4

Research Categories

Growth Hormone Axis

Routes of Administration

Subcutaneous (SQ)
GHRP-2

Pralmorelin · Growth Hormone-Releasing Peptide 2 · KP-102

Phase II

GHRP-2 is a synthetic hexapeptide and potent ghrelin receptor agonist that stimulates growth hormone release from the pituitary. It produces a strong GH pulse with some elevation of cortisol and prolactin at higher doses. Research includes GH deficiency diagnosis, body composition, sleep quality, and appetite stimulation via its ghrelin-mimetic mechanism.

Research Status

phase2

Half-Life

~1–2 hours

Molecular Formula

C₄₅H₅₅N₉O₆

Molecular Weight

817.99 Da

CAS Number

158861-67-7

Research Categories

Growth Hormone Axis, Sleep & Circadian

Routes of Administration

Subcutaneous (SQ)Intranasal

Full mechanism comparison

Mechanism of action, pharmacokinetics, and research findings comparison available on the Researcher plan.

Unlock full comparison →